Who
Cesar L. Alvarez
Director
Company insider
Files Form 4 as: Director, Precigen; Director, Watsco; Director, Pediatrix Medical Group; Director, St. Joe; Director, New River Pharmaceuticals; Director, Atlantis Plastics.
In numbers
- Trades disclosed
- 155
- Buys
- 5
- Sells
- 11
- Bought
- $90K
- Sold
- $12.6M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 19 Jan 2006
- Last trade
- 13 Mar 2026
- Last filed
- 16 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Mar 2026filed 16 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —71,839 | filing |
| 13 Mar 2026filed 16 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —71,839 at $0.00 | filing |
| 13 Mar 2026filed 16 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —71,839 at $0.00 | filing |
| 13 Mar 2026filed 16 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —71,839 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code A | $62K17,806 at $3.51 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,612 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,073 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,612 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,073 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code A | $62K17,806 at $3.51 | filing |
| 14 Mar 2025filed 17 Mar 2025 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —87,412 at $0.00 | filing |
| 14 Mar 2025filed 17 Mar 2025 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —87,412 | filing |
| 13 Mar 2025filed 17 Mar 2025 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,839 at $0.00 | filing |
| 13 Mar 2025filed 17 Mar 2025 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,517 at $0.00 | filing |
| 13 Mar 2025filed 17 Mar 2025 | PGEN PrecigenBiotechnology | SEC FORM 4 Code A | $62K35,919 at $1.74 | filing |
| 5 Mar 2025filed 7 Mar 2025 | WSO Watscooption or derivative · Distributors & Wholesale | SEC FORM 4 Code M | $438K2,500 at $175.07 | filing |
| 5 Mar 2025filed 7 Mar 2025 | WSO Watscooption or derivative · Distributors & Wholesale | SEC FORM 4 Code A | $753K1,500 at $501.67 | filing |
| 5 Mar 2025filed 7 Mar 2025 | WSO WatscoDistributors & Wholesale | SEC FORM 4 Code M | $119K679 at $175.07 | filing |
| 5 Mar 2025filed 7 Mar 2025 | WSO WatscoDistributors & Wholesale | SEC FORM 4 Sold | $339K679 at $498.92 | filing |
| 5 Mar 2025filed 7 Mar 2025 | WSO WatscoDistributors & Wholesale | SEC FORM 4 Code M | $249K1,421 at $175.07 | filing |
News
Watsco, Inc. (NYSE:WSO) Stock Rated "Hold" by Sell-Side AnalystsWSO · dailypolitical.com · 20 Oct 2026Watsco (NYSE:WSO) Stock Gets Price Target Cut from MizuhoWSO · dailypolitical.com · 18 Oct 2026Part of S.R. 23 in St. Joe County will be closed on Oct. 21JOE · abc57.com · 17 Oct 2026St. Joe (NYSE:JOE) Share Price Breaks Above Two Hundred Day Moving Average – Time to Sell?JOE · dailypolitical.com · 16 Oct 2026Hudson Technologies (NASDAQ:HDSN) & Watsco (NYSE:WSO) Critical ReviewWSO · dailypolitical.com · 14 Oct 2026St. Joe properties reopen as cleanup continues after Hurricane IsaiasJOE · wjhg.com · 12 Oct 2026Comparing InfuSystem (NYSE:INFU) & Pediatrix Medical Group (NYSE:MD)MD · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Cesar L. Alvarez; 7 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.